Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDCN has been awarded a renewal of its Athena SWAN Silver Award. This award is a strong endorsement of NDCN’s work to improve gender equality and build a positive research culture.

The Athena SWAN Charter was established in 2005 to encourage and recognise commitment to advance gender equality in higher education and research. The application involves a detailed analysis of staff, student and survey data to identify where we have made progress and areas for further work, with respect to a range of areas including recruitment, induction, career progression, funding applications, professional development, and support for career breaks.

The Silver Award recognises the impact that our work has had on the career development of individuals within the department and in working towards an open and fair workplace culture. The application also includes an ambitious action plan, setting out a number of objectives for the department to continue this work over the coming five years.

Our sincere thanks to NDCN’s Athena SWAN Academic Lead during this process, Associate Professor Katja Wiech, Staff Development Coordinator, Jessica Hedge, and all in the Staff Development Committee and the NDCN Administration Team for their hard work in preparing our application. Finally, thank you to everyone in NDCN who contributed to the application through participating in surveys and focus groups, providing case studies, and reviewing the draft application.

Read more about the University of Oxford's participation in Athena SWAN.

Similar stories

Highly Cited Researchers 2021

Our researchers feature strongly in the latest list

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.